Tirzepatide 10mg Summary Description: Tirzepatide is a novel, dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for the treatment of type 2 diabetes and obesity
Tirzepatide SURMOUNT trials: raising the bar Then came the SURMOUNT trials
Next time, angle the needle toward the vial wall to avoid direct impact
Liraglutide Versus Sitagliptin for Patients With Type 2 Diabetes Who did Not Have Adequate Glycaemic Control With Metformin: A 26-Week, Randomised, Parallel-Group, Open-Label Trial
Summary: GLP-1 monitoring tools for home use include blood glucose meters, digital weight scales, and symptom diaries to track treatment response and identify adverse effects during therapy with medications such as semaglutide or dulaglutide
Book Your Consultation 7690 Belair Road, Suite 1, Baltimore, MD 21236 | 410-368-0420 This article is for informational purposes only and is not medical advice